CM
MRNA icon

Caption Management’s Moderna MRNA Stock Holding History

Caption Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-66,747
Closed -$1.81M – 1900
2025
Q3 		$1.72M Buy
+66,747
New +$1.86M 0.01% 902
2023
Q1 		– Sell
-6,000
Closed -$1.08M – 1373
2022
Q4 		$1.08M Buy
+6,000
New +$981K 0.02% 726
2021
Q1 		– Sell
-29,323
Closed -$4.25M – 1275
2020
Q4 		$3.06M Buy
+29,323
New +$2.97M 0.07% 336

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Caption Management's MRNA Position: Q4 2025 in Review

Caption Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 66,747 shares — an estimated $1.81M sold.

Caption Management first reported a position in MRNA in Q4 2020 and held it in 3 quarters. The position peaked at $3.06M in Q4 2020. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Caption Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 66,747 Moderna shares in Q4 2025, an estimated $1.81M.
  • Caption Management first reported a position in Moderna in Q4 2020 and held it in 3 quarters.
  • Caption Management's Moderna position peaked at $3.06M in Q4 2020.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.